P. Zentilin

发表

Clinical relevance of sampling rate in the characterization and analysis of 24-hour gastric acidity. A report on 413 cases.

G. Mela, V. Savarino, M. Moretti, 1989, Scandinavian journal of gastroenterology.

Alginate controls heartburn in patients with erosive and nonerosive reflux disease.

E. Savarino, V. Savarino, P. Zentilin, 2012, World journal of gastroenterology.

Characteristics of gastro‐esophageal reflux episodes in Barrett’s esophagus, erosive esophagitis and healthy volunteers

E. Savarino, R. Tutuian, D. Pohl, 2010, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

Characteristics of Reflux Episodes and Symptom Association in Patients With Erosive Esophagitis and Nonerosive Reflux Disease: Study Using Combined Impedance–pH Off Therapy

E. Savarino, A. Parodi, R. Tutuian, 2010, The American Journal of Gastroenterology.

Pathophysiological characteristics of patients with non‐erosive reflux disease differ from those of patients with functional heartburn

V. Savarino, P. Zentilin, E. D. Micheli, 2004, Alimentary pharmacology & therapeutics.

Comparison of isotope ratio mass spectrometry and nondispersive isotope-selective infrared spectroscopy for 13C-urea breath test

S. Vigneri, G. Mela, V. Savarino, 1999, American Journal of Gastroenterology.

Endotherapy for and tailored approaches to treating GERD, and refractory GERD

H. Mashimo, E. Savarino, G. Locke, 2013, Annals of the New York Academy of Sciences.

Management Strategy for Patients With Gastroesophageal Reflux Disease: A Comparison Between Empirical Treatment With Esomeprazole and Endoscopy-Oriented Treatment

E. Giannini, S. Vigneri, V. Savarino, 2008, The American Journal of Gastroenterology.

Microscopic esophagitis in gastro-esophageal reflux disease: individual lesions, biopsy sampling, and clinical correlations

R. Fiocca, V. Savarino, P. Zentilin, 2008, Virchows Archiv.

Carditis in patients with gastro‐oesophageal reflux disease: results of a controlled study based on both endoscopy and 24‐h oesophageal pH monitoring

R. Fiocca, S. Vigneri, V. Savarino, 2004, Alimentary pharmacology & therapeutics.

Helicobacter pylori infection is not involved in the pathogenesis of either erosive or non‐erosive gastro‐oesophageal reflux disease

R. Fiocca, S. Vigneri, V. Savarino, 2003, Alimentary pharmacology & therapeutics.

Comparison of the main oesophageal pathophysiological characteristics between short‐ and long‐segment Barrett's oesophagus

V. Savarino, P. Zentilin, S. Vigneri, 2002, Alimentary pharmacology & therapeutics.

Surveillance for Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease: Universal or Selective?

M. Strazzabosco, E. Giannini, M. C. Plaz Torres, 2020, Cancers.

Improvement in hepatitis C virus patients with advanced, compensated liver disease after sustained virological response to direct acting antivirals

E. Giannini, V. Savarino, P. Zentilin, 2019, European journal of clinical investigation.

Gastro-oesophageal reflux and gastric aspiration in idiopathic pulmonary fibrosis patients

E. Savarino, L. Sconfienza, V. Savarino, 2013, European Respiratory Journal.

Eradication of Helicobacter pylori may reduce disease severity in rheumatoid arthritis

V. Savarino, P. Zentilin, P. Dulbecco, 2002, Alimentary pharmacology & therapeutics.

Gastroesophageal reflux and pulmonary fibrosis in scleroderma: a study using pH-impedance monitoring.

E. Savarino, A. Parodi, R. Tutuian, 2009, American journal of respiratory and critical care medicine.

Correlation Between Skin and Affected Organs in 52 Sclerodermic Patients Followed in a Diseases Management Team: Development of a Risk Prediction Model of Organ-Specific Complications

P. Zentilin, A. Parodi, G. Murdaca, 2021, Frontiers in Immunology.

Nuts and Non-Alcoholic Fatty Liver Disease: Are Nuts Safe for Patients with Fatty Liver Disease?

E. Giannini, M. C. Plaz Torres, P. Zentilin, 2020, Nutrients.

Cell proliferation of squamous epithelium in gastro‐oesophageal reflux disease: correlations with clinical, endoscopic and morphological data

R. Fiocca, V. Savarino, P. Zentilin, 2007, Alimentary Pharmacology and Therapeutics.

Latest insights into the hot question of proton pump inhibitor safety - a narrative review.

E. Savarino, V. Savarino, P. Zentilin, 2020, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Prognostic role of mean platelet volume in patients with cirrhosis.

E. Giannini, V. Savarino, P. Zentilin, 2016, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Reassessment of the role of methane production between irritable bowel syndrome and functional constipation.

E. Savarino, E. Giannini, V. Savarino, 2012, Journal of gastrointestinal and liver diseases : JGLD.

Functional heartburn has more in common with functional dyspepsia than with non-erosive reflux disease

E. Savarino, L. Sconfienza, R. Tutuian, 2009, Gut.

A safety review of proton pump inhibitors to treat acid-related digestive diseases

E. Savarino, C. Marinelli, G. Lorenzon, 2018, Expert opinion on drug safety.

Stool antigen assay (HpSA) is less reliable than urea breath test for post‐treatment diagnosis of Helicobacter pylori infection

S. Vigneri, V. Savarino, P. Zentilin, 2002, Alimentary pharmacology & therapeutics.

[Possible connection between gastroesophageal reflux and interstitial pulmonary fibrosis in patients with systemic sclerosis].

E. Savarino, L. Sconfienza, V. Savarino, 2009, Recenti progressi in medicina.

Achalasia with dense eosinophilic infiltrate responds to steroid therapy.

E. Savarino, R. Fiocca, V. Savarino, 2011, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Pharmacotherapies in eosinophilic esophagitis: state of the art.

E. Savarino, E. Giannini, V. Savarino, 2022, Minerva gastroenterology.

No evidence of an association between Helicobacter pylori infection and Raynaud phenomenon.

A. Sulli, V. Savarino, P. Zentilin, 2000, Scandinavian journal of gastroenterology.

Barrett's esophagus: proton pump inhibitors and chemoprevention II

R. Hunt, E. Savarino, P. Bechi, 2011, Annals of the New York Academy of Sciences.

Relevance of Measuring Substances in Bronchoalveolar Lavage Fluid for Detecting Aspiration-associated Extraesophageal Reflux Disease

E. Savarino, V. Savarino, P. Zentilin, 2017, Journal of neurogastroenterology and motility.

Pathophysiological Studies Are Mandatory to Understand the Benefit of Proton Pump Inhibitors in Patients with Idiopathic Pulmonary Fibrosis

E. Savarino, V. Savarino, P. Zentilin, 2016, Journal of neurogastroenterology and motility.

Not All Patients With Non-erosive Reflux Disease Share Psychological Distress as Main Mechanism of Disease

E. Savarino, V. Savarino, P. Zentilin, 2013, Journal of neurogastroenterology and motility.

Normal values of 24-h ambulatory intraluminal impedance combined with pH-metry in subjects eating a Mediterranean diet.

E. Savarino, A. Parodi, S. Vigneri, 2006, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Combined multichannel intraluminal impedance and pH-metry: a novel technique to improve detection of gastro-oesophageal reflux literature review.

E. Savarino, E. Giannini, V. Savarino, 2004, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Effects of Branched-Chain Amino Acids Supplementation in Patients With Cirrhosis and a Previous Episode of Hepatic Encephalopathy: A Randomized Study

E. Savarino, M. Vergara, V. Savarino, 2011, The American Journal of Gastroenterology.

Esophageal baseline impedance levels allow the identification of esophageal involvement in patients with systemic sclerosis.

E. Savarino, A. Sulli, C. Pizzorni, 2018, Seminars in arthritis and rheumatism.

Prevalence of Lactose Intolerance in Patients with Hashimoto Thyroiditis and Impact on LT4 Replacement Dose

E. Savarino, E. Giannini, V. Savarino, 2022, Nutrients.

Bolus Infusion of Famotidine: Effects on Gastric pH by Repeated 12‐Hour Doses of 20 mg in Postoperative Patients

G. Mela, V. Savarino, P. Zentilin, 1994, Journal of clinical pharmacology.

Antisecretory effects of three omeprazole regimens for maintenance treatment in duodenal ulcer

G. Mela, V. Savarino, P. Zentilin, 1994, Digestive Diseases and Sciences.

An evaluation of the antireflux properties of sodium alginate by means of combined multichannel intraluminal impedance and pH‐metry

E. Savarino, A. Parodi, S. Vigneri, 2005, Alimentary pharmacology & therapeutics.

Long-term treatment of patients affected by systemic sclerosis with cyclosporin A.

M. Cutolo, A. Sulli, P. Zentilin, 2001, Annali italiani di medicina interna : organo ufficiale della Societa italiana di medicina interna.

The effects of omeprazole 20 and 40 mg twice daily on intragastric acidity in duodenal ulcer patients.

G. Mela, V. Savarino, P. Zentilin, 1996, Alimentary pharmacology & therapeutics.

Intragastric acidity and serum gastrin after sufotidine.

G. Mela, V. Savarino, P. Zentilin, 1990, Gut.

A Machine Learning Application to Predict Early Lung Involvement in Scleroderma: A Feasibility Evaluation

L. Billeci, S. Gangemi, A. Tonacci, 2021, Diagnostics.

A Comparison Between Sodium Alginate and Magaldrate Anhydrous in the Treatment of Patients with Gastroesophageal Reflux Symptoms

E. Savarino, E. Giannini, V. Savarino, 2006, Digestive Diseases and Sciences.

Cyclosporin A and iloprost treatment of systemic sclerosis: clinical results and interleukin-6 serum changes after 12 months of therapy.

M. Cutolo, A. Sulli, P. Zentilin, 1999, Rheumatology.

Innovative techniques in evaluating the esophagus; imaging of esophageal morphology and function; and drugs for esophageal disease

M. Neurath, M. Vieth, E. Savarino, 2013, Annals of the New York Academy of Sciences.

Comparison of the effects of placebo, ranitidine, famotidine and nizatidine on intragastric acidity by means of continuous pH recording.

G. Mela, V. Savarino, G. Bonifacino, 1989, Digestion.

Continuous acidity monitoring in the study of gastric antisecretory drugs: pH or antilog transformation of pH, mean or median?

G. Mela, V. Savarino, G. Bonifacino, 1990, The American journal of gastroenterology.

24-hour gastric pH-metry analysis: influence of arbitrarily predefined time intervals on the reliability of acidity indexes.

G. Mela, V. Savarino, G. Bonifacino, 1990, The American journal of gastroenterology.

Gastric aspiration versus antimony and glass pH electrodes. A simultaneous comparative in vivo study.

G. Mela, V. Savarino, M. Moretti, 1989, Scandinavian journal of gastroenterology.

Time pattern of gastric acidity in Barrett's esophagus

G. Lapertosa, S. Vigneri, G. Mela, 1996, Digestive Diseases and Sciences.

Twenty‐four‐Hour Control of Gastric Acidity by Twice‐Daily Doses of Placebo, Nizatidine 150 mg, Nizatidine 300 mg, and Ranitidine 300 mg

G. Mela, V. Savarino, P. Zentilin, 1993, Journal of clinical pharmacology.

Single morning and nightly doses of ranitidine 300 mg: an appraisal of their antisecretory effects by continuous pH monitoring.

G. Mela, V. Savarino, A. Sumberaz, 1991, Digestion.

Once and twice daily doses of H2 antagonists revisited, using continuous intragastric pH monitoring.

G. Mela, V. Savarino, A. Sumberaz, 1988, Scandinavian journal of gastroenterology.

Circadian acidity pattern in prepyloric ulcers: a comparison with normal subjects and duodenal ulcer patients.

G. Mela, V. Savarino, P. Zentilin, 1993, Scandinavian journal of gastroenterology.

The appropriate use of proton-pump inhibitors.

E. Savarino, V. Savarino, P. Zentilin, 2018, Minerva medica.

Variability in individual response to various doses of omeprazole

S. Vigneri, V. Savarino, P. Zentilin, 2005, Digestive Diseases and Sciences.

A comparison of the effects on intragastric acidity of bedtime or dinnertime administration of a once daily dose of famotidine

G. Mela, V. Savarino, A. Sumberaz, 2004, European Journal of Clinical Pharmacology.

Low bedtime doses of H2-receptor antagonists for acute treatment of duodenal ulcer

G. Mela, V. Savarino, M. Moretti, 1989, Digestive Diseases and Sciences.

Are duodenal ulcer seasonal fluctuations paralleled by seasonal changes in 24-hour gastric acidity and Helicobacter pylori infection?

G. Lapertosa, G. Mela, V. Savarino, 1996, Journal of clinical gastroenterology.

Mealtime versus nighttime acid inhibition

S. Vigneri, G. Mela, V. Savarino, 1992, Digestive Diseases and Sciences.

Antimony and glass pH electrodes can be used interchangeably in 24-hour studies of gastric acidity

G. Mela, V. Savarino, M. Moretti, 1990, Digestive Diseases and Sciences.

Effect of Helicobacter pylori Eradication on 24-Hour Gastric pH and Duodenal Gastric Metaplasia

G. Lapertosa, S. Vigneri, G. Mela, 2000, Digestive Diseases and Sciences.

Partial regression of Barrett's esophagus by long-term therapy with high-dose omeprazole.

G. Lapertosa, G. Mela, V. Savarino, 1996, Gastrointestinal endoscopy.

Evaluation of 24-hour gastric acidity in patients with hepatic cirrhosis.

G. Mela, V. Savarino, P. Zentilin, 1996, Journal of hepatology.

A pharmacodynamic study of two omeprazole regimens suitable for long-term treatment of duodenal ulcer.

V. Savarino, P. Zentilin, F. Di Mario, 1994, Scandinavian journal of gastroenterology.

A SIGE-SINGEM-AIGO technical review on the clinical use of esophageal reflux monitoring.

E. Savarino, R. Penagini, M. Costantini, 2020, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Achalasia and Obstructive Motor Disorders Are Not Uncommon in Patients with Eosinophilic Esophagitis.

E. Savarino, C. Gyawali, R. Penagini, 2020, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Prevalence and clinical characteristics of refractoriness to optimal proton pump inhibitor therapy in non‐erosive reflux disease

R. Penagini, M. Ribolsi, M. Cicala, 2018, Alimentary pharmacology & therapeutics.

The contribution of intraepithelial inflammatory cells to the histological diagnosis of microscopic esophagitis

C. Tinelli, E. Savarino, R. Fiocca, 2015, Esophagus.

Outcome of nonerosive gastro-esophageal reflux disease patients with pathological acid exposure.

F. Pace, E. Grossi, L. Russo, 2009, World journal of gastroenterology.

Circadian pattern of intragastric acidity in patients with non‐erosive reflux disease (NERD)

G. Mela, V. Savarino, P. Zentilin, 2003, Alimentary pharmacology & therapeutics.

Microscopic esophagitis distinguishes patients with non-erosive reflux disease from those with functional heartburn

E. Savarino, A. Frigo, R. Fiocca, 2013, Journal of Gastroenterology.

Reassessment of the Diagnostic Value of Histology in Patients with GERD, Using Multiple Biopsy Sites and an Appropriate Control Group

E. Savarino, A. Parodi, R. Fiocca, 2005, The American Journal of Gastroenterology.

Is gastric acid hypersecretion the only reason for refractory gastroesophageal reflux disease?

G. Mela, V. Savarino, P. Zentilin, 1990, Gastroenterology.

Oesophageal motility and bolus transit abnormalities increase in parallel with the severity of gastro‐oesophageal reflux disease

E. Savarino, R. Tutuian, D. Pohl, 2011, Alimentary pharmacology & therapeutics.

Vonoprazan Fumarate for the Treatment of Gastric Ulcers: A Short Review on Emerging Data

E. Savarino, B. Barberio, E. Giannini, 2020, Clinical and experimental gastroenterology.

CEG_A_228352 99..104

E. Savarino, B. Barberio, E. Giannini, 2020 .

Review article - esophageal reflux hypersensitivity: Non-GERD or still GERD?

E. Savarino, E. Giannini, S. Tolone, 2020, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

The Role of Nonacid Reflux in NERD: Lessons Learned From Impedance-pH Monitoring in 150 Patients off Therapy

E. Savarino, R. Cestari, R. Tutuian, 2008, The American Journal of Gastroenterology.

An update of pharmacology, efficacy, and safety of vonoprazan in acid-related disorders

E. Savarino, M. Ribolsi, B. Barberio, 2021, Expert review of gastroenterology & hepatology.

Gastrointestinal functional disorders can benefit from the use of medical devices made of substances

V. Savarino, P. Zentilin, M. Furnari, 2023, Frontiers in Drug Safety and Regulation.

Pharmacological Management of Gastro-Esophageal Reflux Disease: An Update of the State-of-the-Art

E. Savarino, V. Savarino, P. Zentilin, 2021, Drug design, development and therapy.

Pathophysiology, diagnosis, and pharmacological treatment of gastro-esophageal reflux disease

E. Savarino, S. Tolone, V. Savarino, 2020, Expert review of clinical pharmacology.

A review of pharmacotherapy for treating gastroesophageal reflux disease (GERD)

E. Savarino, S. Tolone, V. Savarino, 2017, Expert opinion on pharmacotherapy.

Proton pump inhibitors: use and misuse in the clinical setting

E. Savarino, V. Savarino, P. Zentilin, 2018, Expert review of clinical pharmacology.

Circadian Gastric Acidity and Helicobacter pylori Infection in Patients with Chronic Pancreatitis

S. Vigneri, G. Mela, V. Savarino, 2000, Digestive Diseases and Sciences.

Functional testing: pharyngeal pH monitoring and high-resolution manometry.

E. Savarino, R. Penagini, J. Clarke, 2013, Annals of the New York Academy of Sciences.

Appropriateness of proton pump inhibitors treatment in clinical practice: Prospective evaluation in outpatients and perspective assessment of drug optimisation.

E. Giannini, M. C. Plaz Torres, V. Savarino, 2020, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

The Relevance of Reflux Monitoring Off Therapy

E. Savarino, V. Savarino, P. Zentilin, 2011, The American Journal of Gastroenterology.

The added value of impedance-pH monitoring to Rome III criteria in distinguishing functional heartburn from non-erosive reflux disease.

E. Savarino, L. Sconfienza, V. Savarino, 2011, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Low Fibrinogen Levels Are Associated with Bleeding After Varices Ligation in Thrombocytopenic Cirrhotic Patients.

E. Giannini, M. C. Plaz Torres, V. Savarino, 2018, Annals of hepatology.

Advancements in the use of manometry and impedance testing for esophageal functional disorders

E. Savarino, B. Barberio, S. Tolone, 2019, Expert review of gastroenterology & hepatology.

Circadian gastric acidity in Helicobacter pylori positive ulcer patients with and without gastric metaplasia in the duodenum.

G. Mela, V. Savarino, P. Zentilin, 1996, Gut.

Epidemiology and natural history of gastroesophageal reflux disease.

E. Savarino, V. Savarino, P. Zentilin, 2017, Minerva gastroenterologica e dietologica.

Drugs for improving esophageal mucosa defense: where are we now and where are we going?

E. Savarino, V. Savarino, P. Zentilin, 2017, Annals of gastroenterology.

Lactulose breath test to assess oro-cecal transit delay and estimate esophageal dysmotility in scleroderma patients.

E. Savarino, A. Parodi, S. Negrini, 2013, Seminars in arthritis and rheumatism.

Defining esophageal landmarks, gastroesophageal reflux disease, and Barrett's esophagus

E. Savarino, G. Costamagna, R. Souza, 2013, Annals of the New York Academy of Sciences.

Esophagogastric junction morphology is associated with a positive impedance‐pH monitoring in patients with GERD

E. Savarino, S. Roman, F. Galeazzi, 2015, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

Prevention Strategies for Esophageal Cancer—An Expert Review

M. Fassan, E. Savarino, B. Barberio, 2021, Cancers.

Duration of acid suppression in H2-antagonist nonresponders.

G. Mela, V. Savarino, P. Zentilin, 1992, Digestion.

Updates in the field of non-esophageal gastroesophageal reflux disorder

E. Savarino, B. Barberio, G. Lorenzon, 2019, Expert review of gastroenterology & hepatology.

Reduction of hexavalent chromium by fasted and fed human gastric fluid. I. Chemical reduction and mitigation of mutagenicity.

S. De Flora, D. Proctor, M. Suh, 2016, Toxicology and applied pharmacology.

Low Fibrinogen Levels Are Associated with Bleeding After Varices Ligation in Thrombocytopenic Cirrhotic Patients.

E. Giannini, V. Savarino, P. Zentilin, 2018, Annals of hepatology.

Is Helicobacter pylori infection a risk factor for disease severity in rheumatoid arthritis?

S. Accardo, V. Savarino, P. Zentilin, 1999, Gastroenterology.

A 10-day levofloxacin-based therapy in patients with resistant Helicobacter pylori infection: a controlled trial.

E. Savarino, A. Parodi, S. Vigneri, 2004, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

The relevance of symptom association analysis in GORD patients undergoing anti-reflux surgery

E. Savarino, V. Savarino, P. Zentilin, 2011, Gut.

NERD: an umbrella term including heterogeneous subpopulations

E. Savarino, V. Savarino, P. Zentilin, 2013, Nature Reviews Gastroenterology &Hepatology.

Impedance-pH reflux patterns can differentiate non-erosive reflux disease from functional heartburn patients

E. Savarino, R. Tutuian, D. Pohl, 2012, Journal of Gastroenterology.

It is time to plan clinical trials on true NERD patients

E. Savarino, V. Savarino, P. Zentilin, 2012, Neurogastroenterology and Motility.

Overweight is a risk factor for both erosive and non-erosive reflux disease.

E. Savarino, V. Savarino, P. Zentilin, 2011, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Non-Erosive Reflux Disease is More Complex Than Negative Endoscopy Only

E. Savarino, V. Savarino, P. Zentilin, 2013, The American Journal of Gastroenterology.

Nonerosive reflux disease and functional heartburn are clearly separate entities.

E. Savarino, V. Savarino, P. Zentilin, 2013, European journal of gastroenterology & hepatology.

Symptom association analysis is important in GERD patients undergoing endoscopic therapy.

E. Savarino, F. Galeazzi, V. Savarino, 2013, Gastrointestinal endoscopy.

Esophageal acid exposure still plays a major role in patients with NERD

E. Savarino, V. Savarino, P. Zentilin, 2013, Journal of gastroenterology.

The relevance of weakly acidic reflux in patients with Barrett's esophagus.

E. Savarino, V. Savarino, P. Zentilin, 2012, Gastroenterology.

657 Use of a Non-Invasive Pepsin Diagnostic Test to Detect GERD: Correlation With MII-pH Evaluation in a Series of Suspected NERD Patients. A Pilot Study

E. Savarino, M. Bellini, V. Savarino, 2013 .

Hepatobiliary and Pancreatic: A rare cause of portal hypertension

E. Giannini, M. C. Plaz Torres, V. Savarino, 2015, Journal of gastroenterology and hepatology.

Impact of Long-Term Ranitidine and Pantoprazole on Accuracy of [13C]Urea Breath Test

P. Usai, S. Vigneri, V. Savarino, 2003, Digestive Diseases and Sciences.

Comparable Helicobacter pylori eradication rates obtained with 4- and 7-day rabeprazole-based triple therapy: a preliminary study.

P. Usai, S. Vigneri, V. Savarino, 2003, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Negative effect of ranitidine on the results of urea breath test for the diagnosis of Helicobacter pylori

S. Vigneri, V. Savarino, P. Zentilin, 2001, American Journal of Gastroenterology.

Negative effect of ranitidine on the results of urea breath test for the diagnosis of Helicobacter pylori.

S. Vigneri, V. Savarino, P. Zentilin, 2001 .

Histological and functional recovery in patients with multifocal atrophic gastritis after eradication of Helicobacter pylori infection.

G. Lapertosa, G. Mela, V. Savarino, 1999, Italian journal of gastroenterology and hepatology.

Failure of new diagnostic aids in improving detection of pancreatic cancer at a resectable stage

V. Savarino, P. Zentilin, G. Celle, 1983, Digestive Diseases and Sciences.

Air swallowing can be responsible for non-response of heartburn to high-dose proton pump inhibitor.

E. Savarino, V. Savarino, P. Zentilin, 2005, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

OC.03.3: FUNCTIONAL HEARTBURN AND NON-EROSIVE REFLUX DISEASE: THE ADDED VALUE OF IMPEDANCE-PH MONITORING TO ROME III CRITERIA

E. Savarino, V. Savarino, P. Zentilin, 2011 .

Helicobacter pylori and tolerance to H2‐blockers

E. Savarino, V. Savarino, P. Zentilin, 2005, Alimentary pharmacology & therapeutics.

Absence of tolerance in duodenal ulcer patients treated for 28 days with a bedtime dose of roxatidine or ranitidine

V. Savarino, P. Zentilin, S. Vigneri, 1996, Fundamental & clinical pharmacology.

Long-term treatment of patients affected by systemic sclerosis with cyclosporin A.

M. Cutolo, A. Sulli, P. Zentilin, 2001, Rheumatology.

Association between esophageal motor disorders and pulmonary involvement in patients affected by systemic sclerosis: a retrospective study.

E. Savarino, E. Giannini, M. Cutolo, 2023, Rheumatology international.

Comparison of 24‐h control of gastric acidity by three different dosages of pantoprazole in patients with duodenal ulcer

Celle, S. Vigneri, G. Mela, 1998, Alimentary pharmacology & therapeutics.

How safe are heartburn medications and who should use them?

E. Savarino, E. Giannini, V. Savarino, 2023, Expert opinion on drug safety.

Limitations of continuous 24-h intragastric pH monitoring in the diagnosis of duodenogastric reflux.

G. Mela, V. Savarino, P. Zentilin, 1995, American Journal of Gastroenterology.

T1116 Functional Heartburn and Non-Erosive Reflux Disease: the Added Value of Impedance-pH Monitoring to ROME III Criteria

E. Savarino, V. Savarino, P. Zentilin, 2010 .

Overweight is a risk factor for both erosive and non-erosive reflux disease.

E. Savarino, V. Savarino, P. Zentilin, 2011, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Improvement in esophageal motor abnormalities in systemic sclerosis patients treated with cyclosporine: comment on the article by Clements et al.

V. Savarino, P. Zentilin, F. Puppo, 1994, Arthritis and rheumatism.

A review of pharmacotherapy for treating gastroesophageal reflux disease (GERD)

E. Savarino, S. Tolone, V. Savarino, 2017, Expert opinion on pharmacotherapy.

Alginate controls heartburn in patients with erosive and nonerosive reflux disease.

E. Savarino, V. Savarino, P. Zentilin, 2012, World journal of gastroenterology.

Expression of Epidermal Growth Factor receptor (EGFR) in Systemic Sclerosis patients (SSc) and Gastro-oesophageal Reflux Disease (GORD).

E. Savarino, P. Zentilin, L. Mastracci, 2024, Immunology Letters.

Oesophageal motility and bolus transit abnormalities increase in parallel with the severity of gastro‐oesophageal reflux disease

E. Savarino, R. Tutuian, V. Savarino, 2011, Alimentary pharmacology & therapeutics.

Characteristics of gastro‐esophageal reflux episodes in Barrett’s esophagus, erosive esophagitis and healthy volunteers

E. Savarino, R. Tutuian, P. Zentilin, 2010, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

Diagnostic delay in achalasia.

E. Savarino, P. Zentilin, M. Furnari, 2024, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.